Vr Adviser, LLC Kal Vista Pharmaceuticals, Inc. Transaction History
Vr Adviser, LLC
- $414 Million
- Q1 2025
A detailed history of Vr Adviser, LLC transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Vr Adviser, LLC holds 6,703,985 shares of KALV stock, worth $82.1 Million. This represents 18.68% of its overall portfolio holdings.
Number of Shares
6,703,985
Previous 6,249,731
7.27%
Holding current value
$82.1 Million
Previous $52.9 Million
46.15%
% of portfolio
18.68%
Previous 8.73%
Shares
4 transactions
Others Institutions Holding KALV
# of Institutions
141Shares Held
54.4MCall Options Held
1.22MPut Options Held
6K-
Tang Capital Management LLC San Diego, CA4.94MShares$60.5 Million3.7% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.91MShares$60.2 Million2.48% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA4.89MShares$59.9 Million3.55% of portfolio
-
Vestal Point Capital, LP New York, NY4.75MShares$58.2 Million3.92% of portfolio
-
Capital World Investors Los Angeles, CA3.18MShares$38.9 Million0.01% of portfolio
About KalVista Pharmaceuticals, Inc.
- Ticker KALV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,602,000
- Market Cap $301M
- Description
- KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...